论文部分内容阅读
目的:探讨生长抑素联合云南白药治疗门脉高压性上消化道出血的应用效果和对患者的影响。方法:选择2014年4月~2015年5月期间接受治疗的门脉高压性上消化道出血患者60例,以就诊顺序随机分为常规组与实验组,每组各30例,常规组患者接受常规的治疗和护理服务,实验组在常规组的基础上给予生长抑素联合云南白药治疗,对比两组患者的生命质量和临床症状。结果:与常规组比较,实验组有效的生长抑素联合云南白药治疗能够显著改善患者的生活质量和生命质量,改善患者的临床症状和并发症状,治疗效果显著高于常规组。上述数据对比差异显著,有统计学意义(P<0.05)。结论:生长抑素联合云南白药治疗门脉高压性上消化道出血的治疗效果更好和治疗价值更高,能显著改善患者的生活质量,减轻患者的病情,减少术后并发症状发生,值得推广。
Objective: To investigate the effect of somatostatin combined with Yunnanbaiyao on portal hypertensive upper gastrointestinal bleeding and its effect on patients. Methods: Sixty patients with portal hypertensive upper gastrointestinal bleeding who were treated during April 2014 to May 2015 were randomly divided into routine group and experimental group, with 30 cases in each group and patients in routine group Routine treatment and nursing services were given to the experimental group on the basis of the conventional group with somatostatin plus Yunnanbaiyao. The quality of life and clinical symptoms of the two groups were compared. Results: Compared with the conventional group, the effective combination of somatostatin and Yunnanbaiyao in the experimental group could significantly improve the quality of life and quality of life of patients, and improve the clinical symptoms and complications of the patients. The treatment effect was significantly higher than that of the conventional group. The difference between the above data was significant and statistically significant (P <0.05). Conclusion: Somatostatin combined with Yunnanbaiyao treatment of portal hypertension in the treatment of upper gastrointestinal bleeding better and more valuable, can significantly improve the quality of life of patients, reduce the patient’s condition and reduce postoperative complications, is worth promoting .